Overview

Here at Copelands Consulting we believe that we provide a fundamental link between the patient and the industry. Our CEO, Robin Emerson, is the father of Jorja Emerson, who was born with an extremely rare chromosome deletion. This started Robin on a roller coaster journey in 2017, which resulted in Jorja being the first child to get a UK prescription for medical cannabis once the law changed in November 2018. We are truly passionate about the possibilities of what medical cannabis can do and its potential to revolutionise the medical industry over the coming years. However, we are not naïve enough to think that this can not come about without a strong foundation of work and research. Copelands Consulting is a science led company that focuses on providing facts and working with relevant stakeholders to open up access in an appropriate and safe way. Positioned at the forefront of the industry, Copelands Consulting is ideally suited to guide and advise clients on a wide range of topics, from importing products and regulatory framework, to GMP Manufacturing. Copelands Consulting has established a broad spectrum of strategic relationships which allows us to offer a complete solution to our clients.